Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study.

Grinsztejn B, Torres TS, Hoagland B, Coutinho C, Silva MST, Leite IC, Cunha M, Derrico M, Jalil EM, Cardoso SW, Trefiglio R, Farias A, Mourão MPG, Madruga JV, de Lima JN, Zonta R, O'Malley G, Moreira J, Simpson K, Rinehart AR, Pilgrim N, Hellstrom A, Cameron AI, Luz PM, Landovitz RJ, Benedetti M, Pimenta C, Moreira RI, Veloso VG, ImPrEP CAB Brasil Study Group

Open source

DOI: 10.1016/s2352-3018(26)00201-8
Published: 2026 Sep 24
Container: The lancet. HIV
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3018-26-00201-8,
  title = {Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study.},
  author = {Grinsztejn B and Torres TS and Hoagland B and Coutinho C and Silva MST and Leite IC and Cunha M and Derrico M and Jalil EM and Cardoso SW and Trefiglio R and Farias A and Mourão MPG and Madruga JV and de Lima JN and Zonta R and O'Malley G and Moreira J and Simpson K and Rinehart AR and Pilgrim N and Hellstrom A and Cameron AI and Luz PM and Landovitz RJ and Benedetti M and Pimenta C and Moreira RI and Veloso VG and ImPrEP CAB Brasil Study Group},
  year = {2026},
  journal = {The lancet. HIV},
  doi = {10.1016/s2352-3018(26)00201-8},
  url = {https://doi.org/10.1016/s2352-3018(26)00201-8}
}

RIS

TY  - JOUR
TI  - Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study.
AU  - Grinsztejn B
AU  - Torres TS
AU  - Hoagland B
AU  - Coutinho C
AU  - Silva MST
AU  - Leite IC
AU  - Cunha M
AU  - Derrico M
AU  - Jalil EM
AU  - Cardoso SW
AU  - Trefiglio R
AU  - Farias A
AU  - Mourão MPG
AU  - Madruga JV
AU  - de Lima JN
AU  - Zonta R
AU  - O'Malley G
AU  - Moreira J
AU  - Simpson K
AU  - Rinehart AR
AU  - Pilgrim N
AU  - Hellstrom A
AU  - Cameron AI
AU  - Luz PM
AU  - Landovitz RJ
AU  - Benedetti M
AU  - Pimenta C
AU  - Moreira RI
AU  - Veloso VG
AU  - ImPrEP CAB Brasil Study Group
PY  - 2026
JO  - The lancet. HIV
DO  - 10.1016/s2352-3018(26)00201-8
UR  - https://doi.org/10.1016/s2352-3018(26)00201-8
ER  -

APA

B, G., TS, T., B, H., C, C., MST, S., IC, L., M, C., M, D., EM, J., SW, C., R, T., A, F., MPG, M., JV, M., JN, D. L., R, Z., G, O., J, M., K, S., AR, R., N, P., A, H., AI, C., PM, L., RJ, L., M, B., C, P., RI, M., VG, V., & Group, I. C. B. S. (2026). Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study.. The lancet. HIV. https://doi.org/10.1016/s2352-3018(26)00201-8

Source records

pubmed · retrieved 2026-09-26T01:07:51.091Z